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Introduction
Overall Survival of patients with muscle invasive urothe-
lial bladder cancer MIBC remains around 50% (5 years),
albeit some improvements by combining neoadjuvant
chemotherapy with radical surgery. Our previous work
has demonstrated that in vitro expansions of sentinel
node-acquired autologous tumor specific CD4+ T cells
are promising for adoptive immunotherapy [1]. In order
for naive T helper cells to become activated, they need
effective APCs, presenting tumor antigens. In another
study, we observed that B cells in cancer patients were
tumor antigen experienced and from their phenotypes
we suggested a CD4+ T cell dependent anti-tumoral
response [2]. In this study, we report a flow cytometric
investigation of tumor draining lymph node (sentinel
node) derived B cell activation by autologous tumor
extract in patients with MIBC.
Methods
Sentinel nodes (SNs) from 28 patients with MIBC were
detected by a Geiger meter at cystectomy after peritu-
moral injection with radioactive isotope. Lymphocytes
were isolated from freshly received SNs where they were
stimulated with autologous tumor extract in a sterile
environment. After cultivation for 7 days, the cells were
analyzed by multi-color flow cytometry using FASCIA
(Flow cytometric Assay of Specific Cell-mediated
Immune response in Activated whole blood).
Results
Patients displayed an increased B cell activation in SNs
after stimulation with autologous tumor extract compared
to when SN acquired lymphocytes were stimulated with
autologous extract of macroscopically non-malignant blad-
der. CD4+ T cells from SNs were activated and formed
blasts after co-culture with SN acquired B cells in the
presence of tumor antigen. However, CD4+ T cells were
not activated and did not blast when co-cultured with
B cells incubated with HLA-DR-blocking antibodies. This
indicates antigen presenting ability of SN acquired B cells.
Conclusions
We demonstrate sentinel node acquired B lymphocytes
can be activated in culture upon stimulation with autolo-
gous tumor extract but not with extract of non-malignant
epithelium of the bladder, after 7 days. Lower number of
sentinel node acquired CD4+ T cells cultured with HLA-
DR blocked CD19+ cells in presence of tumor antigen,
indicate functional antigen presenting ability of B cells in
sentinel nodes. The role of B cells as APCs in human
T cell anti-tumoral response should be further explored,
as well as their usefulness in adoptive immunotherapy.
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